November 13 (SeeNews) - Raiffeisen Capital & Investment Research said on Tuesday it expects the Romanian drug maker Biofarm [BSE:BIO] to post a third-quarter net profit of 2.7 million lei ($755,400/595,100 euro), flat from a year earlier.